
Daniel T. McKillop
Partner
201-896-7115 dmckillop@sh-law.comFirm Insights
Author: Daniel T. McKillop
Date: August 18, 2017
Partner
201-896-7115 dmckillop@sh-law.comA former NFL player, two children, and an Iraq War veteran suffering from post-traumatic stress disorder, all of whom are medical marijuana patients, together with a social justice nonprofit organization recently filed a federal lawsuit asserting that marijuana’s status as a “Schedule I” narcotic under the Controlled Substances Act (CSA) is so irrational that it violates the U.S. Constitution. The defendants in the case are Attorney General Jeff Sessions, Acting DEA Administrator Charles Rosenberg, the U.S. Justice Department, the DEA and the federal government.
The landmark lawsuit alleges that the federal government’s classification of marijuana was never supported by strong scientific/medical evidence. To be classified under Schedule I, a drug: (i) must have a high potential for abuse; (ii) must have absolutely no medical use in treatment; and (iii) cannot be used or tested safely, even under strict medical supervision.
As highlighted in the suit, a government commission convened in the 1970s under President Richard Nixon recommended that marijuana use should not be criminal or subject someone to an indictment based on its findings that it posed very little risk to the public. “Looking only at the effects on the individual, there, is little-proven danger of physical or psychological harm from the experimental or intermittent use of the natural preparations of cannabis,” the report stated. Nonetheless, President Nixon adopted his own approach, declaring all drug abuse as “public enemy number one in the United States.”
According to the complaint, “The Nixon Administration ushered the CSA through Congress and insisted that cannabis be included on Schedule I so that African Americans and war protesters could be raided, prosecuted and incarcerated without identifying the actual and unconstitutional basis for the government’s actions.”
The lawsuit argues that classifying marijuana as a Class I drug is even more “irrational” today. “Indeed, the Federal Government has admitted repeatedly in writing and implemented national policy reflecting that Cannabis does in fact, have medical uses and can be used and tested safely under medical supervision,” the complaint states. “On that basis, the federal government has exploited cannabis economically for more than a decade by securing a medical cannabis patent and entering into license agreements with medical licensees.”
The suit further contends that the federal government’s refusal to revisit the classification is harming medical marijuana patients and businesses seeking to serve them. One of the plaintiffs is former Dallas Cowboys defensive end Marvin Washington. He is challenging the CSA because it prevents him from obtaining grants under the Federal Minority Business Enterprise program to start a medical marijuana company. Other plaintiffs who are medical marijuana patients maintain that federal criminalization prohibits them from traveling freely by airplane or to states where medical cannabis is illegal, and the Cannabis Cultural Association argues that CSA was enacted and continues to be enforced in a discriminatory manner and prevents minorities from participating in the legal cannabis industry.
If the plaintiffs prevail, the decision would not repeal the CSA but would result in a permanent injunction against enforcement of the CSA with respect to marijuana. The case is venued in the U.S. District Court for the Southern District of New York, Docket No. 1:17-cv-05625. Medical marijuana patients and cannabis industry members should stay apprised of related developments.
This article is a part of a series pertaining to cannabis legalization in New Jersey and the United States at large. Prior articles in this series are below:
If you have any questions or if you would like to discuss the matter further, please contact me, Dan McKillop, at 201-806-3364.
Disclaimer: Possession, use, distribution, and/or sale of cannabis is a Federal crime and is subject to related Federal policy. Legal advice provided by Scarinci Hollenbeck, LLC is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Scarinci Hollenbeck, LLC will not provide assistance in circumventing Federal or state cannabis law or policy, and advice provided by our office should not be construed as such.
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
The Trump Administration’s new tariffs are having an oversized impact on small businesses, which already tend to operate on razor thin margins. Many businesses have been forced to raise prices, find new suppliers, lay off staff, and delay growth plans. For businesses facing even more dire financial circumstances, there are additional tariff response options, including […]
Author: Brian D. Spector
Business partnerships, much like marriages, function exceptionally well when partners are aligned but can become challenging when disagreements arise. Partnership disputes often stem from conflicts over business strategy, financial management, and unclear role definitions among partners. Understanding Business Partnership Conflicts Partnership conflicts place significant stress on businesses, making proactive measures essential. Partnerships should establish detailed […]
Author: Christopher D. Warren
*** The original article was featured on Bloomberg Tax, April 28, 2025 — As a tax attorney who spends much of my time helping people and companies who have large, unresolved issues with the IRS or one or more state tax departments, it often occurs to me that the best service that I can provide […]
Author: Scott H. Novak
On January 28, 2025, the Trump Administration terminated Gwynne Wilcox from her position as a Member of the National Labor Relations Board (NLRB or the Board). Gwynne Wilcox, a union side lawyer for Levy Ratner, was confirmed to the Board for an original term in 2021 and confirmed again for a successive five-year term expiring […]
Author: Matthew F. Mimnaugh
Breach of contract disputes are the most common type of business litigation. Therefore, nearly all New York and New Jersey businesses will likely have to deal with a contract dispute at least once. Understanding when to file a breach of contract lawsuit and how long you have to sue for breach of contract is essential […]
Author: Brittany P. Tarabour
Closing your business can be a difficult and challenging task. For corporations, the process includes formal approval of the dissolution, winding up operations, resolving tax liabilities, and filing all required paperwork. Whether you need to understand how to dissolve a corporation in New York or New Jersey, it’s imperative to take all of the proper […]
Author: Christopher D. Warren
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.
Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.
Let`s get in touch!
Sign up to get the latest from the Scarinci Hollenbeck, LLC attorneys!